EGCG anticancer effects include apoptosis induction, cell proliferation inhibition, and angiogenesis suppression. It targets EGFR, NF-κB, and ROS pathways, showing promise in treating breast, prostate, and pancreatic cancers. Preclinical studies suggest synergistic potential with chemotherapy, enhancing oxidative stress and blocking drug-induced autophagy.
